Abstract | OBJECTIVES: METHODS: We carried out a retrospective study of 158 second-trimester terminations between 12 and 21 weeks' gestation. We compared the intraoperative blood loss among three groups: women without placenta previa undergoing gemeprost termination, women with placenta previa undergoing gemeprost termination and women with placenta previa undergoing dilatation and evacuation (D&E). RESULTS: CONCLUSION: The use of gemeprost for second-trimester pregnancy termination in women with placenta previa seems to be relatively safe and does not increase intraoperative blood loss in the majority of cases.
|
Authors | Daisuke Nakayama, Hideaki Masuzaki, Kiyonori Miura, Koichi Hiraki, Shu-Ichiro Yoshimura, Tadayuki Ishimaru |
Journal | Contraception
(Contraception)
Vol. 75
Issue 3
Pg. 238-40
(Mar 2007)
ISSN: 0010-7824 [Print] United States |
PMID | 17303496
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Abortion, Therapeutic
(adverse effects)
- Adult
- Alprostadil
(analogs & derivatives, pharmacology)
- Blood Loss, Surgical
- Blood Volume
- Dilatation and Curettage
- Female
- Hemorrhage
(epidemiology)
- Humans
- Intraoperative Complications
- Placenta Previa
(surgery)
- Pregnancy
- Pregnancy Trimester, Second
- Retrospective Studies
- Treatment Outcome
- Uterine Hemorrhage
(epidemiology)
|